Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies - PubMed (original) (raw)
Review
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Rocio G Urdinguio et al. Lancet Neurol. 2009 Nov.
Abstract
Epigenetic mechanisms such as DNA methylation and modifications to histone proteins regulate high-order DNA structure and gene expression. Aberrant epigenetic mechanisms are involved in the development of many diseases, including cancer. The neurological disorder most intensely studied with regard to epigenetic changes is Rett syndrome; patients with Rett syndrome have neurodevelopmental defects associated with mutations in MeCP2, which encodes the methyl CpG binding protein 2, that binds to methylated DNA. Other mental retardation disorders are also linked to the disruption of genes involved in epigenetic mechanisms; such disorders include alpha thalassaemia/mental retardation X-linked syndrome, Rubinstein-Taybi syndrome, and Coffin-Lowry syndrome. Moreover, aberrant DNA methylation and histone modification profiles of discrete DNA sequences, and those at a genome-wide level, have just begun to be described for neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, and in other neurological disorders such as multiple sclerosis, epilepsy, and amyotrophic lateral sclerosis. In this Review, we describe epigenetic changes present in neurological diseases and discuss the therapeutic potential of epigenetic drugs, such as histone deacetylase inhibitors.
Comment in
- Epigenetics and the nervous system: epiphenomenon or missing piece of the neurotherapeutic puzzle?
Ratan RR. Ratan RR. Lancet Neurol. 2009 Nov;8(11):975-7. doi: 10.1016/S1474-4422(09)70276-5. Lancet Neurol. 2009. PMID: 19833291 Free PMC article. No abstract available.
Similar articles
- Epigenetic Basis of Lead-Induced Neurological Disorders.
Wang T, Zhang J, Xu Y. Wang T, et al. Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878. Int J Environ Res Public Health. 2020. PMID: 32645824 Free PMC article. Review. - Epigenetic programming of neurodegenerative diseases by an adverse environment.
Babenko O, Kovalchuk I, Metz GA. Babenko O, et al. Brain Res. 2012 Mar 20;1444:96-111. doi: 10.1016/j.brainres.2012.01.038. Epub 2012 Jan 24. Brain Res. 2012. PMID: 22330722 Review. - Epigenetics of neurological diseases.
Shanker OR, Kumar S, Dixit AB, Banerjee J, Tripathi M, Sarat Chandra P. Shanker OR, et al. Prog Mol Biol Transl Sci. 2023;198:165-184. doi: 10.1016/bs.pmbts.2023.01.006. Epub 2023 Mar 17. Prog Mol Biol Transl Sci. 2023. PMID: 37225320 - The role of genetics in the establishment and maintenance of the epigenome.
Huidobro C, Fernandez AF, Fraga MF. Huidobro C, et al. Cell Mol Life Sci. 2013 May;70(9):1543-73. doi: 10.1007/s00018-013-1296-2. Epub 2013 Mar 10. Cell Mol Life Sci. 2013. PMID: 23474979 Free PMC article. Review. - [Epigenetics and etiology of neurodegenerative diseases].
Gruber BM. Gruber BM. Postepy Hig Med Dosw (Online). 2011 Aug 19;65:542-51. doi: 10.5604/17322693.956497. Postepy Hig Med Dosw (Online). 2011. PMID: 21918257 Review. Polish.
Cited by
- The epigenetic modification of DNA methylation in neurological diseases.
Li L, Chen R, Zhang H, Li J, Huang H, Weng J, Tan H, Guo T, Wang M, Xie J. Li L, et al. Front Immunol. 2024 Sep 23;15:1401962. doi: 10.3389/fimmu.2024.1401962. eCollection 2024. Front Immunol. 2024. PMID: 39376563 Free PMC article. Review. - Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease.
Tokairin K, Ito M, Lee AG, Teo M, He S, Cheng MY, Steinberg GK. Tokairin K, et al. Transl Stroke Res. 2024 Oct 2. doi: 10.1007/s12975-024-01299-w. Online ahead of print. Transl Stroke Res. 2024. PMID: 39356405 - Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.
Yao W, Hu X, Wang X. Yao W, et al. Signal Transduct Target Ther. 2024 Sep 16;9(1):232. doi: 10.1038/s41392-024-01918-w. Signal Transduct Target Ther. 2024. PMID: 39278916 Free PMC article. Review. - Estrogen Receptors: A New Frontier in Alzheimer's Disease Therapy.
Cipriano GL, Mazzon E, Anchesi I. Cipriano GL, et al. Int J Mol Sci. 2024 Aug 21;25(16):9077. doi: 10.3390/ijms25169077. Int J Mol Sci. 2024. PMID: 39201762 Free PMC article. Review. - An Overview of the Epigenetic Modifications in the Brain under Normal and Pathological Conditions.
Lossi L, Castagna C, Merighi A. Lossi L, et al. Int J Mol Sci. 2024 Mar 30;25(7):3881. doi: 10.3390/ijms25073881. Int J Mol Sci. 2024. PMID: 38612690 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical